(Q48658737)

14 February 2018

title

Intraneuronally injected amyloid β inhibits long-term potentiation in rat hippocampal slices. (English)

1 reference

14 February 2018

main subject

long-term potentiation

1 reference

Izumi Nomura

1

1 reference

14 February 2018

Hajime Takechi

series ordinal

2

1 reference

14 February 2018

Nobuo Kato

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

15 February 2012

1 reference

14 February 2018

Journal of Neurophysiology

published in

1 reference

14 February 2018

volume

107

1 reference

14 February 2018

issue

9

1 reference

14 February 2018

page(s)

2526-2531

1 reference

14 February 2018

Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

cites work

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Prion protein in Alzheimer's pathogenesis: a hot and controversial issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Homer: a protein that selectively binds metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intraneuronal Abeta42 accumulation in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

APP processing and synaptic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Neurophysiological mechanisms of electroconvulsive therapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

vesl, a gene encoding VASP/Ena family related protein, is upregulated during seizure, long-term potentiation and synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

The role of intracellular amyloid beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Alzheimer's disease and Abeta toxicity: from top to bottom

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Regulation of NMDA receptor trafficking by amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Amyloid beta-peptide: the inside story

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with Homer1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.00589.2011

21 January 2018

Identifiers

DOI

10.1152/JN.00589.2011

1 reference

14 February 2018

1 reference

14 February 2018